Condition: Ischemic Stroke · Transient Ischemic Attack (TIA) · Sponsor: Beijing Tiantan Hospital
This study will conduct a cluster randomized controlled trial to Evaluate whether the Intelligent Lipid Management Decision-support System can increase the proportion of patients 1-year target achievement (\<1.8 mmol/L) in acute ischemic stroke or TIA patients under Evolocumab treatment within 12 months post-intervention.
This description comes directly from the study's public registry record.
Jie Xu · 59975672 · xujie@ncrcnd.org.cn
Aichun Cheng · 13240768490 · aichuncheng0822@163.com
Always discuss trial participation with your own doctor first.
| Beijing Tiantan Hospital | Beijing, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07143149